Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health…
Key facts
- Attack vector
- Network
- Privileges required
- Low
- User interaction
- None
- Attack complexity
- Low
- Impact type
- —
- Confidentiality · integrity · availability
- High · None · None
- Fix status
- No fix listed
Attack profile from CVSS 3.1 · CNA. Fix status from CNA.
Summary
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
Why it matters now
SSVC decision points
CISA ADP · SSVC 2.0.3
- Exploitation
- None
- Automatable
- No
- Technical impact
- Partial
The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.
Affected products
Remediation
No fixed version listed by the sources yet.
Fixed in the same release
Records fixed by the same vendor advisory or release, as the CNA lists them.
- Advisory ·
Oracle Life Sciences Central Designer — oracle.com/security-alerts/cpujan2026.html
3 records Highest priority Priority LOW 3 LOW
Other records, highest priority first
- TI-2026-17673 Information disclosure in Oracle Life Sciences Central DesignerPriority LOW 30
- TI-2026-17623 Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health…Priority LOW 30
Timeline
- 2026-10-02 Threatist record created from CVE-2026-21970
- 2026-10-03 Alias added: GHSA-rj7m-3hcr-7qr4
References
Advisory 1
More Oracle Life Sciences Central Designer vulnerabilities
- TI-2026-17673 Information disclosure in Oracle Life Sciences Central Designer CVSS 3.1MEDIUM 5.3
- TI-2026-17623 Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health… CVSS 3.1MEDIUM 6.5
Sources
- CVE-2026-21970 · CVE Program
- CVE-2026-21970 · NVD
- FIRST EPSS
- GHSA-rj7m-3hcr-7qr4 · GitHub Advisory Database · CC BY 4.0
This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences